New patent for TEVA drug AUSTEDO XR

siteadmin July 30, 2024

DrugPatentWatch reports on AUSTEDO XR, a Teva marketed drug with ten patents and twenty patent family members in eighteen countries. The only generic ingredient in AUSTEDO XR is deutetrabenazine. It is supplied by one company.

Source: www.drugpatentwatch.com - Read more